Stock Movers: Uber's Profit Outlook Miss, Eli Lilly's Sales Surge, Chipotle's Flat Growth

Uber's Financial Performance and Future Investments

• 📉 Uber's stock experienced a significant drop, down 7% in pre-market trading, following a disappointing first-quarter adjusted EBITDA forecast.
• 💡 The company is signaling further investment in its driverless vehicle technology by promoting an outspoken executive to its new chief financial officer role.
• 🚀 Uber is also expanding its robo-taxi services, with plans to launch in Hong Kong and Houston.

Eli Lilly's Strong Sales and Market Dominance

• 📈 Eli Lilly is a major winner in the obesity drug market, with its shares up 7% in pre-market trading after an upbeat sales forecast.
• 💰 The company expects topline growth of up to 27% this year, driven by strong demand for its weight loss drugs, Mounjaro and Zepbound.
• ⚠️ This contrasts sharply with rival Novo Nordisk, which warned of potential sales drops due to intensifying price competition.

Chipotle's Sales Challenges and Outlook

• 📉 Chipotle Mexican Grill is facing extended sales doldrums, with its full-year sales target falling short of Wall Street expectations.
• 📊 The company projects comparable sales to be "about flat" this year, marking its first annual drop in comparable sales.
• 💡 Management is attempting to pivot operations, with protein offerings showing early success in the fourth quarter.

Potential Acquisition: Silicon Labs

• 🚀 Silicon Labs shares soared 25% in pre-market trading on rumors that Texas Instruments is in talks to acquire the chip designer for approximately $7 billion.
• 🧩 This potential acquisition would expand Texas Instruments' analog chip business by incorporating Silicon Labs' internet of things chips.